Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’
Yesterday
FDA+
FDA's oncology adcomm to review GSK's Blenrep relaunch plans
Yesterday
FDA+
With HIV prevention under attack, how might Gilead’s new PrEP injection fare?
2 days ago
In Focus
Moderna wins expanded label for RSV shot, allowing use in at-risk, younger adults
2 days ago
FDA+
Minnesota generic drug pricing law is likely unconstitutional, appeals court rules
2 days ago
Law
Novo Nordisk plans Phase 3 trials of oral, injectable amycretin for early 2026
2 days ago
R&D
Kennedy's vaccine doubts hinge on 'inert' placebos, but experts say he misunderstands the science
2 days ago
FDA+
In surprise, FDA approves UroGen's chemo-turned-gel drug after negative adcomm vote
2 days ago
FDA+
Exclusive: Kennedy picks for vaccine advisory board were paid experts against Merck in civil cases
2 days ago
R&D
FDA+
RFK Jr. names eight new ACIP members, including popular vaccine critic Robert Malone
3 days ago
FDA+
Trump officials seek price details and weigh consumer sales as they examine most favored nation plan
3 days ago
Trump’s HHS urges against reviving Chamber of Commerce’s IRA lawsuit
3 days ago
Law
Federal officials schedule three listening sessions this summer to address drug competition
3 days ago
Nuvation Bio scores first FDA approval for new lung cancer drug
3 days ago
FDA+
Have sky-high sales projections set the obesity market up to fail?
4 days ago
In Focus
Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in March
4 days ago
People
Cell/Gene Tx
Argenx says its drug Vyvgart looks promising in two more autoimmune diseases
4 days ago
R&D
FDA’s Makary says he wasn’t part of decision to gut ACIP, defers possible VRBPAC changes to Prasad
4 days ago
R&D
FDA+
GoodRx goes toe-to-toe with Hims, Ro as it pushes into ED treatment
5 days ago
Health Tech
Updated: HHS chief Kennedy removes all ACIP members, dismantling vaccine board
5 days ago
FDA+
FDA adds biomarker limits to stomach, esophageal cancer labels for Merck's Keytruda and BMS' Opdivo
5 days ago
FDA+
Updated: Merck wins FDA approval for RSV antibody drug, making a hot market more competitive
5 days ago
R&D
FDA+
In a break from other biotechs, Twist Bioscience throws support behind tariffs on synthetic DNA
5 days ago
Manufacturing
Sanofi leans into 'first-mover advantage' by shipping Beyfortus early, as RSV antibody market set to heat up
6 days ago
Manufacturing
1
2
3
4
Next page
Last page